Healthcare Sales & Marketing Network News: antibacterial

Searching News Database: antibacterial

HSMN NewsFeed - 21 Oct 2025
Onkos Surgical(R) Receives FDA 510(k) Clearance for ELEOS(TM) Proximal Tibia with NanoCept(R) Antibacterial Technology
Devices Orthopaedic FDA

HSMN NewsFeed - 29 Mar 2022
Medline and Hologenix Partner on New Curad Performance Series Line Powered By Celliant
Devices Orthopaedic Distribution

HSMN NewsFeed - 12 Aug 2021
Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
Devices Surgery Venture Capital

HSMN NewsFeed - 17 Mar 2021
Peptilogics Strengthens Leadership Team with Three Strategic Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2020
Obiltoxaximab Receives Marketing Authorization From European Commission For The Treatment Of Inhalation Anthrax
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Sep 2020
Medtronic TYRX(TM) Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections
Devices Cardiology

HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 18 Jun 2020
Almirall Announces FDA Approval Of Updated Label For Seysara(R) (Sarecycline) Tablets
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jun 2020
F2G's Olorofim Receives Both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP Designation for Multiple Fungal Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Jun 2020
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Apr 2020
Insmed Appoints Carol A. Schafer to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 30 Jan 2020
Insmed Appoints Sara Bonstein as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Nov 2019
AN2 Therapeutics Launches with $12 Million in Series A Funding and Announces a Strategic Partnership with Brii Biosciences
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Oct 2019
Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane
Biopharmaceuticals Generics

HSMN NewsFeed - 18 Mar 2019
Allergan Announces FDA Approval of AVYCAZ(R) (ceftazidime and avibactam) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Nov 2018
FDA Approves AEMCOLO(TM) (rifamycin), the First Antibiotic Approved for the Treatment of Travelers' Diarrhea in Over a Decade
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 8 Oct 2018
Getinge Launches Maquet PowerLED II
Devices Surgery Product Launch

HSMN NewsFeed - 19 Jul 2018
BioPharmX Announces FDA Grant of CARC Waiver and Post-Hoc Analysis for BPX-01
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals

HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2017
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 5 Oct 2017
Mylan Launches First AP-rated Generic Avelox(R) Injection
Biopharmaceuticals Product Launch

HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2017
Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Mar 2017
Pfizer Launches Zavicefta(TM) (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria
Biopharmaceuticals Product Launch

HSMN NewsFeed - 8 Mar 2017
Spero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Sep 2016
MicuRx Closes $55 Million Series C Financing to Support Development of Next-Generation Antibiotic MRX-I
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 22 Aug 2016
Ethicon Establishes Unmatched Knotless Suture Portfolio With Launch Of STRATAFIX(TM) Spiral Plus Devices
Devices Surgery Product Launch

HSMN NewsFeed - 23 Jun 2016
Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ(R) (ceftazidime and avibactam)
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jun 2016
Allecra Therapeutics Announces €22 Million Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 May 2016
Allergan Receives FDA Approval of TEFLARO(R) (ceftaroline fosamil) for Pediatric Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 20 May 2016
Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO(TM)
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Mar 2016
Biota Pharmaceuticals Announces Sale of Antibiotic Assets to Spero Therapeutics
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Feb 2016
FDA Accepts and Grants Priority Review for AVYCAZ(R) (ceftazidime and avibactam) Supplemental New Drug Application (sNDA)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Feb 2016
FDA Accepts Supplemental New Drug Application (sNDA) for TEFLARO(R) (ceftaroline fosamil)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital

HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jan 2016
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for DALVANCE(R) (dalbavancin)
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Dec 2015
Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Sep 2015
Vomaris and Metrex(TM) Announce Exclusive Distribution Agreement for Procellera(R) Technology in Long Term Care Market
Devices Wound Care Distribution

HSMN NewsFeed - 14 Aug 2015
Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2015
Entasis Appoints Robin David Isaacs as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2015
Spero Completes $30 Million Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Feb 2015
Cidara Therapeutics Completes $42 Million Private Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 30 Jan 2015
Vomaris and Arthrex announce exclusive global distribution agreement for Procellera(R) Technology
Devices Wound Care Orthopaedic Distribution

HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Jan 2015
OCuSOFT(R) Introduces HypoChlor(TM) Spray and Gel (Hypochlorous Acid 0.02%) As Adjunct Therapy to its Lid Scrub(R) Family of Eyelid Cleansers
Biopharmaceuticals Ophthalmology Product Launch

HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Dec 2014
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
Biopharmaceuticals Product Launch

HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jul 2014
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE(TM) (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jun 2014
ORBACTIV(TM) (Oritavancin) Phase 3 Trial Results Published in New England Journal of Medicine
Biopharmaceuticals

HSMN NewsFeed - 24 Feb 2014
SCYNEXIS Appoints Carole Sable, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jan 2014
Sarasota Medical Products to License Stay-Fresh(R) Antimicrobial Technology for Use in Ostomy and Wound Care Products
Devices Wound Care Licensing

HSMN NewsFeed - 6 Jan 2014
Medtronic Announces Acquisition of TYRX, INC., Developer of Solutions for Surgical Site Infections
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Dec 2013
AmpliPhi Biosciences Closes $18 Million Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Dec 2013
Cellceutix Files Orphan Drug Designation Application for Brilacidin for Oral Mucositis with US FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 12 Dec 2013
CorMedix Announces First Sales of Neutrolin(R) in the European Union
Biopharmaceuticals Product Launch

HSMN NewsFeed - 4 Dec 2013
The Medicines Company Acquires Rempex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Nov 2013
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2013
Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Sep 2013
Aptalis Pharma(TM) Launches PYLERA(R) 10 Day Therapy PAK in the United States
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 7 Aug 2013
TYRX Announces First U.S. Implantation of AIGISRx(R) R Fully Bioresorbable Antibacterial Envelope
Devices Cardiology Surgery

HSMN NewsFeed - 23 Jul 2013
TYRX Receives FDA Clearance for AIGISRx(R) Neuro Antibacterial Envelope
Devices Neurosurgery FDA

HSMN NewsFeed - 17 Jul 2013
Sequella Acquires Exclusive Worldwide Rights to Pfizer’s Sutezolid, Currently in Clinical Development for Tuberculosis
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Jul 2013
TYRX Receives FDA Clearance for Fully Resorbable AIGISRx(R) R Antibacterial Envelope
Devices Surgery Cardiology FDA

HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personalized Medicine Personnel

HSMN NewsFeed - 13 May 2013
Optimer Pharmaceuticals Appoints Eric Sirota as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2013
Use of TYRX Antibacterial Envelope Associated with Extremely Low 90-Day Cardiac Device Infection Rates
Devices Cardiology

HSMN NewsFeed - 22 Mar 2013
Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 Implantations
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 28 Feb 2013
FDA Grants QIDP and Fast Track Designations for Cubist’s Late-Stage Antibiotic Candidates
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Dec 2012
FDA Grants Accelerated Approval for SIRTURO(TM) (bedaquiline) as Part of Combination Therapy to Treat Adults with Pulmonary Multi-Drug Resistant Tuberculosis
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2012
BioAdvance Expands Team to Support Portfolio Companies and New Investments
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 15 Oct 2012
AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Oct 2012
XDx Appoints Peter Maag as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 24 Jul 2012
Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2012
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Apr 2012
Optimer Pharmaceuticals Announces Personnel Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Feb 2012
Forest Laboratories Receives European Marketing Approval for Colobreathe(R) Dry Powder Inhaler
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Jan 2012
Chief Operating Officer Tessie M. Che Departing Company
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2011
Soliris(R) (eculizumab) Granted Marketing Authorization in Europe for Treatment of Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Sep 2011
Astellas and Theravance Announce European Marketing Authorization for VIBATIV(R) for Nosocomial Pneumonia Caused by MRSA
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Sep 2011
Nexera Medical, Inc. Announces That It Plans to Submit New Data to the U.S. Food and Drug Administration (FDA) to Amend Its Current 510k Medical Device Clearance to Include Certain Strains of Viruses
Devices

HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 May 2011
Mylan to Rebrand Matrix Laboratories
Biopharmaceuticals

HSMN NewsFeed - 3 May 2011
Optimer Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2011
Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2010
Forest Announces FDA Approval of Teflaro(TM) (ceftaroline fosamil) for the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Oct 2010
Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Sep 2010
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2010
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Jun 2010
Salix Pharmaceuticals Announces NDA Submission For XIFAXAN550 For Treatment of Non-Constipation Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 12 May 2010
Sagent Pharmaceuticals Announces FDA Approval of Bacitracin for Injection, USP
Biopharmaceuticals FDA

HSMN NewsFeed - 6 May 2010
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Apr 2010
FDA Provides Clearance of TYRX Antibacterial Patch for Soft Tissue Repair
Devices Surgery FDA

HSMN NewsFeed - 13 Apr 2010
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation*
Devices Drug Delivery Cardiology

HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Apr 2010
Cempra Announces Expansion of Clinical Management Team to Advance Leading Antibacterial Clinical Programs TAKSTA(TM) and CEM-101
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Mar 2010
TYRX Enrolls First Patient in CITADEL Study for AIGISRx Anti-Bacterial Envelope with ICD Replacements
Devices Cardiology

HSMN NewsFeed - 25 Feb 2010
Derma Sciences Finalizes Licensing Agreement for Worldwide Rights to MEDIHONEY(R)
Devices Wound Care Licensing

HSMN NewsFeed - 13 Jan 2010
AstraZenenca and CrystalGenomics, Inc. Form Research Collaboration to Develop Novel Anti-Infective Treatments
Biopharmaceuticals

HSMN NewsFeed - 23 Dec 2009
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Dec 2009
Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Devices Wound Care Licensing

HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Nov 2009
Basilea's Toctino(R) receives marketing authorization in Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Biopharmaceuticals

HSMN NewsFeed - 14 Oct 2009
Basilea's Toctino(R) receives marketing authorization in Switzerland
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 8 Oct 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Oct 2009
Astellas and Theravance Announce Approval of VIBATIV(TM) (telavancin) in Canada for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Aug 2009
Hemostatic HemCon(R) Dressings selected by the Premier healthcare alliance for Hemostasis Products Contract
Devices Group Purchasing

HSMN NewsFeed - 12 Aug 2009
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
Biopharmaceuticals

HSMN NewsFeed - 22 Jul 2009
Medline Awarded Premier Contract for Soaps, Lotions and Waterless Hand Rinses
Devices Distribution Group Purchasing

HSMN NewsFeed - 29 May 2009
Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye')
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 14 May 2009
Cempra Pharmaceuticals Closes $46 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 May 2009
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 5 May 2009
Basilea's Toctino(R) receives marketing authorization in Spain
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 29 Apr 2009
Basilea's Toctino(R) Receives Marketing Authorization in Netherlands
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Mar 2009
Basilea's Toctino(R) receives marketing authorization in Austria
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 11 Mar 2009
Basilea's Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 24 Feb 2009
Basilea Pharmaceutica files claims against Johnson&Johnson over its handling of ceftobiprole (ZEFTERA(TM)/Zevtera(TM)) clinical studies
Biopharmaceuticals Litigation

HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Dec 2008
Basilea Pharmaceutica opens U.S. phase III study on alitretinoin for the treatment of severe chronic hand eczema
Biopharmaceuticals Dermatology

HSMN NewsFeed - 21 Nov 2008
Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in France
Biopharmaceuticals Regulatory Dermatology

HSMN NewsFeed - 15 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 22 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 9 Sep 2008
Pfizer Will Withdraw Global Marketing Applications for Dalbavancin to Conduct a New Trial
Biopharmaceuticals Regulatory FDA

HSMN NewsFeed - 8 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 2 Sep 2008
Taking the Gold with Silver: B. Braun Introduces Industry-First Silver Impregnated Needle-Free Luer Access Device
Devices FDA

HSMN NewsFeed - 11 Aug 2008
HemCon Bandages Receive Expanded Indications for Antibacterial Barrier, Including MRSA
Devices FDA Wound Care

HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Biopharmaceuticals

HSMN NewsFeed - 3 Jul 2008
Nabriva Therapeutics Announces Appointment of New CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jul 2008
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2008
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Jun 2008
GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
Biopharmaceuticals

HSMN NewsFeed - 11 Jun 2008
Honey, Silver Among Novel Wound Care Treatments
Devices Wound Care

HSMN NewsFeed - 29 May 2008
Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals FDA

HSMN NewsFeed - 14 May 2008
TyRx Pharma, Inc. Announces the First Human Implant of the AIGISRX(TM) Anti-Bacterial Envelope in Cardiac Patient
Devices Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Apr 2008
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial Data
Biopharmaceuticals

HSMN NewsFeed - 15 Apr 2008
Medivir Enters Co-Promotion Agreement with GlaxoSmithKline (GSK)
Biopharmaceuticals

HSMN NewsFeed - 4 Mar 2008
Targanta Strengthens Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jan 2008
Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2007
Pfizer Receives Approvable Letter from FDA for Dalbavancin
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2007
Oculus Innovative Sciences Announces Completion of Two Randomized Controlled Clinical Trials of Microcyn(R) Technology in China
Biopharmaceuticals Wound Care

HSMN NewsFeed - 26 Nov 2007
Achillion Announces Appointment of New Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals

HSMN NewsFeed - 15 Oct 2007
FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 9 Oct 2007
Basilea Announces Positive Top-line Data from Phase III Study of Ceftobiprole in Hospital-Acquired Pneumonia
Biopharmaceuticals

HSMN NewsFeed - 8 Oct 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients with Diabetic Foot Infections
Biopharmaceuticals Wound Care

HSMN NewsFeed - 8 Oct 2007
Cyclacel Pharmaceuticals Acquires Specialty Pharmaceutical Business Focused on the Oncology Market
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2007
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2007
New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 14 Sep 2007
Canadian Regulatory Authority has Accepted for Review New Drug Submission for Ceftobiprole
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Sep 2007
Basilea Announces the Submissions of Marketing Authorization Applications in the EU for Alitretinoin, an Investigational Drug for the Treatment of Severe Refractory Chronic Hand Eczema
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 13 Aug 2007
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jul 2007
New Study Finds Tindamax(R) to be Effective, Well-Tolerated Treatment for Bacterial Vaginosis
Biopharmaceuticals

HSMN NewsFeed - 17 Jul 2007
Basilea Announces Filing of New Drug Submission in Canada for Ceftobiprole
Biopharmaceuticals

HSMN NewsFeed - 12 Jul 2007
Xechem International Announces Change in Its CEO; Offers Update on Nigerian Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2007
Trius Therapeutics Recruits Former J&J Clinician as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2007
Advancis Pharmaceutical Changes Its Name to MiddleBrook Pharmaceuticals, Inc.
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2007
Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 25 Jun 2007
MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jun 2007
Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Jun 2007
Anacor Names Paulette Dillon as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Jun 2007
Trius Therapeutics Recruits Merck Executive to Lead Drug Development Efforts
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2007
Swiss Regulatory Authority Grants Accelerated Assessment of Planned Market Authorization Application for Ceftobiprole
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 May 2007
FDA Approves Tindamax(R) for Bacterial Vaginosis
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 21 May 2007
Efficacy and Safety Profile of Basilea's Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
Biopharmaceuticals Dermatology

HSMN NewsFeed - 18 May 2007
New Drug Application Submitted For Novel Investigational Antibiotic Ceftobiprole
Biopharmaceuticals FDA

HSMN NewsFeed - 1 May 2007
ActivBiotics, Inc. Appoints Steven C. Gilman Chairman and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2007
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
Biopharmaceuticals Dermatology

HSMN NewsFeed - 23 Apr 2007
Advancis Pharmaceutical Appoints New Board Member
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Apr 2007
Xechem Receives $7 Million from New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Apr 2007
GSK Announces FDA Approval of Altabax(TM) (Retapamulin Ointment), 1%
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Apr 2007
Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Mar 2007
Affinium Pharmaceuticals Closes US$18 Million Series A to Advance Clinical Development of Novel Antibacterial Compound
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2007
Schering-Plough Announces Executive Changes in Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Enters into License Agreement with Dong-A Pharmaceuticals for Novel Anti-bacterial Agent
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Feb 2007
Trius Therapeutics Completes $20 Million Series A Financing and Names CEO
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 19 Feb 2007
Basilea Reports Positive Phase III Results for Alitretinoin
Biopharmaceuticals

HSMN NewsFeed - 16 Feb 2007
Inspire Licenses AzaSite(TM) For Ocular Infections
Biopharmaceuticals Ophthalmology Licensing

HSMN NewsFeed - 13 Feb 2007
Advancis Pharmaceutical Announces FDA Decision That its Amoxicillin PULSYS NDA is Not Complete
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Feb 2007
Targanta Announces $70 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Feb 2007
Arrow International, Inc., Adds Hi-Lite Orange(TM) Tinted ChloraPrep(R) to All Central Venous Access Kits
Devices

HSMN NewsFeed - 5 Feb 2007
Targanta Adds Executives to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Jan 2007
Basilea Announces Positive Top-Line Results On Second Pivotal Phase III Ceftobiprole Trial
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
SkinMedica Launches NeoBenz(R) Micro SD for Acne
Biopharmaceuticals Dermatology Drug Delivery

HSMN NewsFeed - 20 Dec 2006
FDA Approves New Indication for INVANZ(R) (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Dec 2006
Basilea Announces Start of Phase III Program for Isavuconazole, Its Third Investigational Drug to Reach Pivotal Trials
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Basilea to Co-Promote Ceftobiprole
Biopharmaceuticals

HSMN NewsFeed - 28 Nov 2006
Abraxis BioScience Receives FDA Approval for Ampicillin and Sulbactam for Injection, 15g, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 Nov 2006
AMDL Announces Launch of Antibiotic Levofloxacin in China
Biopharmaceuticals Regulatory

HSMN NewsFeed - 31 Oct 2006
Advancis Pharmaceutical Submits Proposed Order in Corporate Name Infringement Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 23 Oct 2006
Advancis Pharmaceutical Announces Promotion of Robert Bannon to Vice President, Investor Relations & Corporate Communications
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Oct 2006
Advancis Pharmaceutical Announces Promotion of Robert C. Low to Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2006
Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress
Biopharmaceuticals

HSMN NewsFeed - 10 Oct 2006
Achaogen Closes Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Oct 2006
Aisling Capital Joins I. Wistar Morris III and Intersouth Partners as a Lead Investor in Cempra Pharmaceuticals
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Sep 2006
Basilea Reports Excellent Pivotal Data for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Investigational Antibiotic, at ICAAC
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
New Data Confirming Broad Spectrum of Basilea's Late-Stage Antifungal, BAL8557, Presented at the ICAAC Conference
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2006
Advancis Pharmaceutical Receives Judgment in Trademark Infringement Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 18 Sep 2006
Targanta Appoints Mark Leuchtenberger, Former President and CEO of Therion Biologics Corporation, as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2006
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jul 2006
Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2006
Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex
Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
Advancis Pharmaceutical Receives FDA Approval Letter for New Strengths of Keflex
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 131

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 131 additional stories matching:
antibacterial
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!